Chronic Lower Back Pain Market

Apr 28, 2020

10 likes | 25 Views

The market size of Chronic Lower Back Pain in the 7MM is expected to grow at a CAGR of 3.55% for the study period, 2017u2013 2030. Among the 7MM countries, the United States had the highest market size of Chronic low back pain (CLBP) in 2017, which accounts for approximately 62.18% of the total market. In 2017, the total Prevalent Population of Chronic low back pain (CLBP) in the 7MM was found to be 73,802,461. The key players in Chronic Lower Back Pain (CLBP) Market includes Braeburn Pharmaceuticals, Camurus, Regeneron Pharmaceuticals, Teva Pharmaceutical, Pfizer, Eli Lilly and Company, Mesoblast, Egalet Corporation, Axsome Therapeutics, Allodynic Therapeutics, Astellas Pharma, Gru00fcnenthal GmbH, Frontier Biotechnologies, DiscGenics, Yuhan Corporation, Semnur Pharmaceuticals, Sollis Therapeutics, SpineThera, Stayble Therapeutics, AnGes MG and many others. For more detailed information visit: https://www.delveinsight.com/report-store/chronic-lower-back-pain-clbp-market #backpain #lowerback #chronicpain #CLBP #Muscularpain #Radicularpain #pharmaceutical #healthcare #lifesciences #biotechnology

DelveInsight

Download Presentation

Chronic Lower Back Pain Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D